Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.76 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | NR2F2 | P24468 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2288114 | 1.00 | SLC29A1 (0.76) | SLC29A1ADORA3TP53TDP1NPC1 | |
| SCHEMBL27183207 | 1.00 | SLC29A1 (0.76) | SLC29A1ADORA3TP53TDP1NPC1 | |
| SCHEMBL21011278 | 1.00 | SLC29A1 (0.76) | SLC29A1ADORA3TP53TDP1NPC1 | |
| SCHEMBL14873532 | 1.00 | SLC29A1 (0.76) | SLC29A1ADORA3TP53TDP1NPC1 | |
| SCHEMBL23982158 | 1.00 | SLC29A1 (0.76) | SLC29A1ADORA3TP53TDP1NPC1 | |
| SCHEMBL2288108 | 1.00 | SLC29A1 (0.76) | SLC29A1ADORA3TP53TDP1NPC1 | |
| SCHEMBL19582971 | 0.91 | SLC29A1 (0.77) | SLC29A1ADORA3TP53TDP1HIF1A | |
| SCHEMBL14873502 | 0.90 | SLC29A1 (0.76) | SLC29A1ADORA3TP53TDP1ADORA1 | |
| SCHEMBL13467483 | 0.90 | SLC29A1 (0.76) | SLC29A1HIF1A | |
| SCHEMBL20626371 | 0.90 | SLC29A1 (0.76) | SLC29A1ADORA3TP53TDP1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210338706-A1 | ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2021-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210338706-A1 | ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK | PER2, CRY1, ADORA2A | SLC29A1 450/4885ADORA3 13/4885TP53 4641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.